TSMC

TSMC delivered a Q1 2026 print that confirmed it as the single chokepoint of the entire AI infrastructure cycle. Revenue of $35.90 billion (+40.6% YoY in USD) beat consensus of $35.5 billion, net income surged 58.3% YoY to NT$572.48 billion, and diluted EPS of NT$22.08 topped estimates of NT$20.88. The advanced-node mix is the real story: 7nm and below now constitutes 74% of total wafer revenue, with 3nm contributing 25%, 5nm at 36%, and the High Performance Computing platform reaching 61% of revenue (up from 55% in Q4 2025 and 51% a year earlier).

What makes TSM unique in 2026 is the 2nm node ramp. Volume production starts H2 2026, and Apple has already booked over half of initial 2nm capacity for the A20 application processor and M6 chip — locking up the most-advanced node before NVIDIA, AMD, or any third party gets meaningful allocation. Q2 2026 guidance calls for revenue of $39.0-40.2 billion (implying further sequential acceleration) at gross margins of 65.5-67.5%. CEO C.C. Wei guided full-year 2026 revenue growth above 30% in USD terms with capex toward the high end of the $52-56 billion range. The Arizona fab program — $165 billion committed across up to 12 fabs over the next decade — is now firmly de-risked: the first fab (4nm) is operational, the second (3nm) is under construction, and N2 (2nm) production is planned for late this decade.

TSM has unusual smart-money composition: it is one of Warren Buffett’s best-known sales (initiated and exited within ~6 months in 2023, with Buffett citing geopolitical risk as the reason). However, that sale was at roughly $80 per share; TSM now trades above $190, and Buffett has not re-entered. Among other BMI-tracked managers, Mohnish Pabrai initiated a position in late 2023 and has held through 2025-2026; the position appears in Pabrai Investment Funds 13F filings at roughly 6% of portfolio. Stanley Druckenmiller cycled through TSM in 2024 but does not currently hold.

The institutional flow narrative for 2026 has shifted: the geopolitical-risk discount that Buffett cited in 2023 has compressed materially as Arizona-fab progress demonstrates a viable de-Taiwan production path. Insider activity at TSM is structurally less observable than at U.S. peers because of Taiwan disclosure regulations — but Q1 13F flows from Goldman Sachs, Morgan Stanley, and Citadel-tracked institutional accounts show net buying through the quarter. The most-watched event remains the Arizona N2 (2nm) production timeline, which Senior VP Y.P. Chyn confirmed at the April 2026 Tech Symposium would target late-2027 startup — earlier than prior consensus of 2028.

TSM trades at $192 per share (ADR), roughly 20× consensus 2026 EPS of $9.60 and 16.5× 2027 EPS — a meaningful discount to fabless customers like NVIDIA at 19× and AMD at 22-24×, despite having superior gross margin (65%+) and structurally lower customer-concentration risk than the smaller foundries. On EV/EBITDA, TSM trades at approximately 11× versus Samsung Foundry at 8× (correctly discounted for trailing yield issues) and Intel Foundry at 5× (correctly discounted for mid-tier process competitiveness). Wall Street consensus across 38 covering firms averages $235 (Morgan Stanley $245, Goldman $240, Bernstein $215), implying ~22% upside. The valuation is among the cheapest mega-cap AI infrastructure exposure on the public market — discounted only because of geopolitical-risk overhang that Arizona is actively dismantling.

1. July 17, 2026 (estimated): Q2 2026 earnings — first quarter to confirm whether Q2 revenue lands within the $39.0-40.2 billion guidance band; gross margin upper-end (67.5%) would signal 2nm yield is exceeding plan
2. September 2026: Apple iPhone 18 Pro launch with A20 (2nm) — first commercial product on TSMC 2nm node, validating yield, capacity ramp, and per-wafer pricing power
3. Late 2027: Arizona N2 (2nm) startup — earlier than prior consensus of 2028 per Senior VP Chyn’s April 2026 confirmation; first U.S. production of leading-edge AI accelerator silicon, structurally reducing geopolitical discount

TSM is the cleanest AI-infrastructure compounder I track, and arguably the most undervalued mega-cap in the entire chip complex. You get 65%+ gross margins, 30%+ revenue growth, the structural monopoly position in advanced-node fabrication, and a 20× forward multiple that compares against NVIDIA at 19× — even though TSMC carries materially less customer-concentration risk and benefits when ANY of the top three accelerator customers wins share. My add-trigger is any Q2 print where revenue lands in the upper half of the $39.0-40.2 billion guide AND gross margin exceeds 66.5% — that combination would signal 2nm yield is trending favorably and Apple’s capacity booking is converting to high-margin shipments. I would not chase TSM above $215; I am building the position aggressively in the $180-195 zone where the geopolitical discount remains overstated relative to Arizona progress. The thesis breaks if Taiwan Strait tensions escalate to direct kinetic risk — a scenario I don’t handicap above 5% probability over 24 months but cannot rule out.